At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
IBB iShares Biotechnology ETF
Trading 09-15 14:03:11 EDT
202.26
-2.33
-1.14%
High204.15Low200.55Vol999.74K
Open203.82D1 Closing204.59Amplitude1.76%
Mkt Cap10.31BTradable Cap10.31BTotal Shares50.95M
T/O202.02MT/O Rate1.96%Tradable Shares50.95M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Sector Update: Healthcare
MT Newswires Live  ·  58 minutes ago
Sector Update: Healthcare
Gilead Sciences Expands Lenacapavir Access to 14 Countries
MT Newswires Live  ·  09-15 23:43
Gilead Sciences Expands Lenacapavir Access to 14 Countries
Gilead announces agreement with PAHO for lenacapavir access
TIPRANKS  ·  09-15 23:15
Gilead announces agreement with PAHO for lenacapavir access
Gilead: Explores Opportunities with Brazilian Health Ministry to Advance Ministry’s Goal of Enabling Local Production of Lenacapavir
THOMSON REUTERS  ·  09-15 23:10
Gilead: Explores Opportunities with Brazilian Health Ministry to Advance Ministry’s Goal of Enabling Local Production of Lenacapavir
Gilead: Agreement Establishes Regional Pathway Through Pan American Health Organization's Regional Revolving Funds
THOMSON REUTERS  ·  09-15 23:10
Gilead: Agreement Establishes Regional Pathway Through Pan American Health Organization's Regional Revolving Funds
Gilead: Co & Paho Announce Partnership to Accelerate Access to Twice-Yearly Lenacapavir for Hiv Prevention Across Latin America & Caribbean
THOMSON REUTERS  ·  09-15 23:10
Gilead: Co & Paho Announce Partnership to Accelerate Access to Twice-Yearly Lenacapavir for Hiv Prevention Across Latin America & Caribbean
Gilead, PAHO Agree on HIV Prevention Drug Access in Latin America, Caribbean
Reuters  ·  09-15 23:10
Gilead, PAHO Agree on HIV Prevention Drug Access in Latin America, Caribbean
Gilead: to Continue Exploring Opportunities to Work with Paho to Support Country Readiness & Scale-up of Long-Acting Hiv Prevention Access
THOMSON REUTERS  ·  09-15 23:10
Gilead: to Continue Exploring Opportunities to Work with Paho to Support Country Readiness & Scale-up of Long-Acting Hiv Prevention Access
Gilead Exec Says Weekly Oral Hiv Prevention Drug Expected to Launch in First Quarter of 2027 - Conf Call
THOMSON REUTERS  ·  09-15 23:04
Gilead Exec Says Weekly Oral Hiv Prevention Drug Expected to Launch in First Quarter of 2027 - Conf Call
Gilead Exec Says Hiv Market Growth Should Normalize to 2%-3% Within Next Couple of Quarters - Conf Call
THOMSON REUTERS  ·  09-15 23:04
Gilead Exec Says Hiv Market Growth Should Normalize to 2%-3% Within Next Couple of Quarters - Conf Call
Sector Update: Healthcare
MT Newswires Live  ·  09-15 20:56
Sector Update: Healthcare
Amgen Announces Dividend of R$ 0.31 Per Unit, Payable Sept. 17
Reuters  ·  09-15 20:17
Amgen Announces Dividend of R$ 0.31 Per Unit, Payable Sept. 17
Press Release: Legend Biotech Appoints Ingrid Zhang as Chief Executive Officer
Dow Jones  ·  09-15 20:00
Press Release: Legend Biotech Appoints Ingrid Zhang as Chief Executive Officer
Vertex Pharmaceuticals partners with Lindsey Vonn for JOURNAVX awareness
TIPRANKS  ·  09-15 19:36
Vertex Pharmaceuticals partners with Lindsey Vonn for JOURNAVX awareness
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC), Natera (NTRA) and Vertex Pharmaceuticals (VRTX)
TIPRANKS  ·  09-15 19:20
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC), Natera (NTRA) and Vertex Pharmaceuticals (VRTX)
Amgen to deploy Veeva Vault CRM globally
TIPRANKS  ·  09-15 19:10
Amgen to deploy Veeva Vault CRM globally
Barclays downgrades Scholar Rock on valuation after FDA approval
TIPRANKS  ·  09-15 17:10
Barclays downgrades Scholar Rock on valuation after FDA approval
Sino Biopharmaceutical Stock Slips 1.0% in Hong Kong
Dow Jones  ·  09-15 16:33
Sino Biopharmaceutical Stock Slips 1.0% in Hong Kong
Actinogen Medical Seeks ASX Quotation for 21.9 Million New Shares
TIPRANKS  ·  09-15 12:47
Actinogen Medical Seeks ASX Quotation for 21.9 Million New Shares
Prescient Therapeutics Extends Securities Purchase Plan Deadline
TIPRANKS  ·  09-15 10:02
Prescient Therapeutics Extends Securities Purchase Plan Deadline

Introduction

Company Name.
iShares Biotechnology ETF
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Issue price:
--